Sitagliptin Phosphate



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 57.5%
Diabetes Mellitus 12.2%
Hypertension 11.4%
Dyslipidaemia 2.8%
Procedural Complication 1.9%
Product Used For Unknown Indication 1.9%
Bipolar Disorder 1.7%
Atrial Fibrillation 1.4%
Gastrooesophageal Reflux Disease 1.4%
Hypercholesterolaemia 1.1%
Polyarthritis 1.1%
Neuropathy Peripheral 0.8%
Prophylaxis 0.8%
Angina Pectoris 0.6%
Anxiety 0.6%
Cardiovascular Event Prophylaxis 0.6%
Coronary Artery Disease 0.6%
Depression 0.6%
Hyperlipidaemia 0.6%
Neuralgia 0.6%
Hypoglycaemia 11.5%
Pancreatic Carcinoma 11.5%
Vomiting 8.2%
Cerebrovascular Accident 6.6%
Overdose 6.6%
Cerebral Haemorrhage 4.9%
Death 4.9%
Dyspnoea 4.9%
Sepsis 4.9%
Anaemia 3.3%
Chronic Lymphocytic Leukaemia 3.3%
Drug Eruption 3.3%
Hospitalisation 3.3%
Interstitial Lung Disease 3.3%
Intestinal Obstruction 3.3%
Large Intestine Carcinoma 3.3%
Lung Neoplasm Malignant 3.3%
Myocardial Infarction 3.3%
Off Label Use 3.3%
Pancreatitis 3.3%
Secondary
Type 2 Diabetes Mellitus 30.9%
Diabetes Mellitus 17.7%
Product Used For Unknown Indication 17.2%
Hypertension 11.5%
Drug Use For Unknown Indication 2.4%
Bipolar Disorder 2.2%
Gastrooesophageal Reflux Disease 2.2%
Anxiety 2.1%
Pain 2.1%
Dyslipidaemia 1.9%
Cardiac Failure 1.5%
Asthma 1.0%
Constipation 1.0%
Diabetic Neuropathy 1.0%
Hypertriglyceridaemia 1.0%
Insomnia 1.0%
Cerebral Infarction 0.9%
Irritability 0.9%
Acute Coronary Syndrome 0.7%
Atrial Fibrillation 0.7%
Pancreatic Carcinoma 9.8%
Abdominal Pain Upper 7.3%
Hypoglycaemia 7.3%
Ketoacidosis 7.3%
Vomiting 6.1%
Granulomatous Liver Disease 4.9%
Hepatic Cirrhosis 4.9%
Lipase Increased 4.9%
Rectal Haemorrhage 4.9%
Renal Failure Acute 4.9%
Wrong Technique In Drug Usage Process 4.9%
Blood Pressure Diastolic Decreased 3.7%
Circulatory Collapse 3.7%
Cytolytic Hepatitis 3.7%
Dehydration 3.7%
Drug Eruption 3.7%
International Normalised Ratio Increased 3.7%
Nephropathy 3.7%
Overdose 3.7%
Pneumonia Mycoplasmal 3.7%
Concomitant
Drug Use For Unknown Indication 21.8%
Diabetes Mellitus 18.5%
Hypertension 11.8%
Product Used For Unknown Indication 10.2%
Type 2 Diabetes Mellitus 8.3%
Hepatitis C 4.4%
Rheumatoid Arthritis 4.0%
Schizophrenia 3.2%
Prophylaxis 3.1%
Blood Cholesterol Increased 2.3%
Hyperlipidaemia 1.6%
Constipation 1.5%
Pain 1.5%
Depression 1.5%
Insomnia 1.2%
Cancer Pain 1.2%
Hypercholesterolaemia 1.1%
Blood Cholesterol 1.0%
Breast Cancer 1.0%
Back Pain 1.0%
Anaemia 7.3%
Loss Of Consciousness 7.3%
Tremor 7.3%
Myalgia 6.6%
Blood Glucose Increased 5.8%
Pruritus 5.8%
Myocardial Infarction 5.1%
Rash 5.1%
Somnolence 5.1%
White Blood Cell Count Decreased 5.1%
Diabetes Mellitus 4.4%
Hypoglycaemia 4.4%
Pneumonia 4.4%
Renal Impairment 4.4%
Vomiting 4.4%
Flushing 3.6%
Hypertension 3.6%
Hypoaesthesia 3.6%
Paraesthesia 3.6%
Altered State Of Consciousness 2.9%
Interacting
Type 2 Diabetes Mellitus 100.0%
Drug Interaction 71.4%
Rhabdomyolysis 28.6%